[1]
|
Mosher, W.D., Martinez, G.M., Chandra, A., Abma, J.C. and Wilson, S.J. (2004) Use of contraception and use of family planning services in the United States: 1982-2002. Advanced Data, 10, 1-36.
|
[2]
|
Trussel, J. (2004) Contraceptive failure in the United States. Contraception, 70, 89-96.
http://dx.doi.org/10.1016/j.contraception.2004.03.009
|
[3]
|
Melo, N. And Zuccato, A.P. (2004) Satisfaction and non contraceptive benefits with Nuvaring, a novel vaginal combined contraceptive method in a clinical experience program in Brazil. European Journal of Contraception Reproduction Heath Care, 9, 93-98.
|
[4]
|
Novak, A., de la Loge, C., Abetz, L. and van der Meulen, E.A. (2003) The combined contraceptive vaginal ring, NuvaRing: An international study of user acceptability. Contraception, 67, 187-194.
http://dx.doi.org/10.1016/S0010-7824(02)00514-0
|
[5]
|
Potter, L., Oakley, D., de León-Wong, E. and Canamar, R. (1996) Measuring compliance among oral contraceptive users. Family Planning Perspectives, 28, 154-158.
http://dx.doi.org/10.2307/2136191
|
[6]
|
Burkman, R.T. (2001) Oral contraceptives: Current status. Clinical Obstetrics and Gynecology, 44, 62-72.
http://dx.doi.org/10.1097/00003081-200103000-00010
|
[7]
|
Creinim, M.D., Meyn, L.A., Borgatta, L., Barnhart, K., Jensen, J., Burke, A.E., Westhoff, C., Gilliam, M., Dutton, C. and Ballagh, S.A. (2008) Estudo multicêntrico comparando anel e adesivo na contracep??o. Obstetrics & Gynecology, 111, 267-277.
|
[8]
|
Food and Drug Administration (Estados Unidos) (2001) “sz” (PDF), 8.
http://www.fda.gov/cder/ foi/nda/2001/21-187_NuvaRing_corres_P1.pdf
|
[9]
|
Bitzer, J. (2012) The vaginal ring (NuvaRing®) for contraception in adolescent women. Gynecological Endocrinology, 28, 125-129.
http://dx.doi.org/10.3109/09513590.2011.579665
|
[10]
|
Carey, A.S., Chiappetta, L., Tremont, K., Murray, P.J. and Gold, M.A. (2007) The contraceptive vaginal ring: Female adolescents’ knowledge, attitudes and plans for use. Contraception, 76, 444-450.
http://dx.doi.org/10.1016/j.contraception.2007.07.013
|
[11]
|
Lete, I., Doval, J.L., Pérez-Campos, E., et al. (2007) Factors affecting women’s selection of a combined hormonal contraceptive method: The TEAM-06 Spanish cross-sectional study. Contraception, 76, 77-83.
http://dx.doi.org/10.1016/j.contraception.2007.04.014
|
[12]
|
Ahrendt, H.J., Nisand, I., Bastianelli, C., et al. (2006) Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone. Contraception, 74, 451-457.
http://dx.doi.org/10.1016/ j.contraception.2006.07.004
|
[13]
|
Fine, P.M., Tryggestad, J., Meyers, N.J. and Haghpeykar, H.S. (2007) Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion. Contraception, 75, 367-371.
http://dx.doi.org/10.1016/j.contraception.2007.01.009
|
[14]
|
Schafer, J.E., Osborne, L.M., Davis, A.R. and Westhoff, C. (2006) Acceptability and satisfaction using quick start with the contraceptive vaginal ring versus an oral contraceptive. Contraception, 73, 488-492.
http://dx.doi.org/10.1016/j.contraception.2005.11.003
|
[15]
|
Westhoff, C.L., Heartwell, S., Edwards, S., et al. (2007) Oral contraceptive discontinuation: Do side effects matter? American Journal of Obstetrics & Gynecology, 196, 411-417. http://dx.doi.org/10. 1016/j.ajog.2006.12.015
|
[16]
|
Roumen, F.J., Apter, D., Mulders, T.M. and Dieben, T.O. (2001) Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyloestradiol. Human Reproduction, 16, 469-475.
http://dx.doi.org/10.1093/humrep/16.3.469
|
[17]
|
Oddsson, K., Leifels-Fischer, B., Wiel-Masson, D., et al. (2005) Superior cycle control with a contraceptive vaginalring compared with an oral contraceptive containing 30 microgethinylestradiol and 150 microglevonorgestrel: A randomized trial. Human Reproduction, 20, 557-562.
http://dx.doi.org/10.1093/humrep/deh604
|
[18]
|
Roumen, F.J. and Mishell Jr., D.R. (2012) The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. European Journal of Contraception Reproduction Heath Care, 17, 415-427.
http://dx.doi.org/10.3109/13625187.2012.713535
|